Last reviewed · How we verify

NCT02998463

Facilitating Skin-to-Skin Contact In the Postnatal Period

Completed NA Last updated 26 July 2019
What this trial tests

NA trial testing skin-to-skin facilitating garment in Breast Feeding in 110 participants. Completed in 20 June 2019.

Timeline
31 March 2017
Primary endpoint
20 June 2019
20 June 2019

Quick facts

Lead sponsorBirmingham City University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment110
Start date31 March 2017
Primary completion20 June 2019
Estimated completion20 June 2019
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Birmingham City University

Who can join

16 and older, female only, with Breast Feeding or Body Temperature Changes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the safety and efficacy of a skin-to-skin facilitating garment used by mother-infant dyads. It has three phases including researcher observation, randomised controlled trialing and qualitative midwifery staff perspective. The research will determine the effect a facilitating garment has in comparison to conventionally facilitated skin-to-skin contact, by measuring its effect on the baby's temperature stability, breastfeeding status and weight velocity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Feeding

Currently open trials in the same condition.

Other Birmingham City University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02998463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing